In addition, with very low specificity of the PSA test for cancer diagnosis and limitation of imaging technologies to identify residual cancer lesions after treatment, no accurate test is available to assess efficacy and outcome of PCa treatment such as prostatectomy. Here, KLK3 is linked to posterior cortical atrophy.